Department of Health and Human Services June 5, 2017 – Federal Register Recent Federal Regulation Documents

Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: 2017-11512
Type: Notice
Date: 2017-06-05
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at https:// www.samhsa.gov/workplace.
National Institute of General Medical Sciences; Notice of Closed Meeting
Document Number: 2017-11498
Type: Notice
Date: 2017-06-05
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Aging; Notice of Closed Meetings
Document Number: 2017-11497
Type: Notice
Date: 2017-06-05
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings
Document Number: 2017-11496
Type: Notice
Date: 2017-06-05
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings
Document Number: 2017-11495
Type: Notice
Date: 2017-06-05
Agency: Department of Health and Human Services, National Institutes of Health
Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting
Document Number: 2017-11494
Type: Notice
Date: 2017-06-05
Agency: Department of Health and Human Services, National Institutes of Health
The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on June 23, 2017. The subject of the meeting will be ``Measurement Science and Glycemic Control.'' The meeting is open to the public.
Government-Owned Inventions; Availability for Licensing
Document Number: 2017-11492
Type: Notice
Date: 2017-06-05
Agency: Department of Health and Human Services, National Institutes of Health
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Prospective Grant of Exclusive Patent License: Production of Attenuated West Nile Virus Vaccines
Document Number: 2017-11491
Type: Notice
Date: 2017-06-05
Agency: Department of Health and Human Services, National Institutes of Health
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Commercialization Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Summary Information section of this notice to the International Medica Foundation located in Shoreview, Minnesota, U.S.A.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.